Using medication-assisted treatment for substance use disorders: Evidence of barriers and facilitators of implementation
- 30 June 2011
- journal article
- Published by Elsevier BV in Addictive Behaviors
- Vol. 36 (6), 584-589
- https://doi.org/10.1016/j.addbeh.2011.01.032
Abstract
No abstract availableFunding Information
- National Institute on Drug Abuse, the National Institute on Alcohol Abuse and Alcoholism
This publication has 22 references indexed in Scilit:
- Barriers to the implementation of medication-assisted treatment for substance use disorders: The importance of funding policies and medical infrastructureEvaluation and Program Planning, 2011
- A longitudinal study of organizational formation, innovation adoption, and dissemination activities within the National Drug Abuse Treatment Clinical Trials NetworkJournal of Substance Abuse Treatment, 2010
- Facilitating Factors and Barriers to the Use of Medications in Publicly Funded Addiction Treatment OrganizationsJournal of Addiction Medicine, 2010
- The adoption of alcohol pharmacotherapies in the Clinical Trials Network: The influence of research network participationJournal of Substance Abuse Treatment, 2010
- Buprenorphine adoption in the National Drug Abuse Treatment Clinical Trials NetworkJournal of Substance Abuse Treatment, 2009
- A categorical typology of naltrexone-adopting private substance abuse treatment centersJournal of Substance Abuse Treatment, 2008
- Improving Care for the Treatment of Alcohol and Drug DisordersThe Journal of Behavioral Health Services & Research, 2008
- Innovation adoption in substance abuse treatment: Exposure, trialability, and the Clinical Trials NetworkJournal of Substance Abuse Treatment, 2007
- The adoption of medications in substance abuse treatment: Associations with organizational characteristics and technology clustersDrug and Alcohol Dependence, 2007
- Early adoption of buprenorphine in substance abuse treatment centers: Data from the private and public sectorsJournal of Substance Abuse Treatment, 2006